Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed Combination Bimatoprost/Timolol Ocular Insert in Glaucoma/OHT
NCT02742649Phase 2Completed
- Sponsor
- ForSight VISION5
- Start
- Apr 2016
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bimatoprost and timolol in open-angle glaucoma (OAG) and ocular hypertension (3 arms), sponsored by ForSight VISION5. Primary endpoint: Intraocular Pressure at Day 70. Started Apr 2016; status: completed.
02
Drugs
bimatoprosttimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02742649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02742649.